TickerLeague

Buyback Spend for IQVIA (IQV)

Buyback Spend for IQVIA (IQV): headline value $2.28B · YoY -7.9%. Annual and quarterly series, chart, and tables are below.

Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .

Latest period

$2.28B

YoY change

-7.9%

5Y CAGR

+22.7%

Peak year (2017)

$2.62B

Latest annual

$1.24B

Buyback Spend history chart for IQVIA (IQV) from 2010 to 2025

Buyback Spend history table for IQVIA (IQV) from 2010 to 2025

Fiscal yearPeriod endedReportedBuyback SpendYoY
2025$1.24B-7.9%
2024$1.35B+36.1%
2023$992.00M-15.1%
2022$1.17B+187.7%
2021$406.00M-9.2%
2020$447.00M-52.9%
2019$949.00M-32.5%
2018$1.41B-46.4%
2017$2.62B+138.8%
2016$1.10B+113.0%
2015$515.01M+24.1%
2014$415.00M+6350.1%
2013$6.43M-51.9%
2012$13.36M-6.7%
2011$14.32M+53.4%
2010$9.34M

Buyback Spend values are taken from IQVIA's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

Analysis

IQVIA (IQV) most recent annual buyback spend stands at $1.24B (2025) – declined 7.9% year-over-year.

Looking at the 2020–2025 (5 years) stretch, IQVIA buyback spend compounded at +22.7% per year, with the latest reading among the more recent periods of the dataset.

IQVIA buyback spend plunged from $2.62B in 2017 to $1.24B in 2025, a 52.5% drawdown.

2017 marks the peak buyback spend at $2.62B, with the historical low of $6.43M recorded in 2013.

IQVIA (IQV) sits 6th of 8 Healthcare peers we track on this metric, against a peer median of $2.75B.

IQVIA Buyback Spend by Year

IQVIA Buyback Spend 2025: $1.24B

IQVIA buyback spend in 2025 was $1.24B, declined 7.9% below 2024.

IQVIA Buyback Spend 2024: $1.35B

IQVIA buyback spend in 2024 was $1.35B, surged 36.1% from 2023.

IQVIA Buyback Spend 2023: $992.00M

IQVIA buyback spend in 2023 was $992.00M, declined 15.1% below 2022.

IQVIA Buyback Spend 2022: $1.17B

IQVIA buyback spend in 2022 was $1.17B, surged 187.7% from 2021.

IQVIA Buyback Spend 2021: $406.00M

IQVIA buyback spend in 2021 was $406.00M.

See more financial history for IQVIA (IQV).

Sector peers — Buyback Spend

Companies in the same sector as IQVIA, ranked by their latest buyback spend.

CompanyBuyback SpendSector
Johnson & Johnson (JNJ)$5.95BHealthcare
UnitedHealth Group Incorporated (UNH)$5.54BHealthcare
Merck & Co., Inc. (MRK)$5.08BHealthcare
Eli Lilly and Company (LLY)$4.11BHealthcare
Novo Nordisk A/S (NVO)$1.39BHealthcare
AbbVie Inc. (ABBV)$980.00MHealthcare
AstraZeneca PLC (AZN)$719.66MHealthcare
Amgen Inc. (AMGN)$0Healthcare

Frequently asked questions

What is IQVIA's buyback spend?

Latest reported buyback spend for IQVIA (IQV) is $2.28B (period ending December 31, 2025).

How has IQVIA buyback spend changed year-over-year?

IQVIA (IQV) buyback spend changed -7.9% year-over-year on the latest annual filing.

What is the long-term growth rate of IQVIA buyback spend?

IQVIA (IQV) buyback spend compound annual growth rate is +22.7% over the most recent 5 years available.

When did IQVIA buyback spend hit its highest annual value?

IQVIA buyback spend reached its highest annual value of $2.62B in 2017.

What was IQVIA buyback spend in 2024?

IQVIA (IQV) buyback spend in 2024 was $1.35B.

What was IQVIA buyback spend in 2025?

IQVIA (IQV) buyback spend in 2025 was $1.24B.

Metrics overview

Pick a metric for charts, filings and peers — each row shows the latest TTM or most-recent-quarter value.